Reference
EAU 2025 guidelines
Every European Association of Urology 2025 guideline — a board-prep summary with the key recommendations up top, then the complete recommendation tables with Strong / Weak grades.
19 guidelines·EAU 2025·For educational use only
EAU 2025 Guidelines: Renal Cell Carcinoma
Evidence-based recommendations on the diagnosis, staging, prognostic stratification, and management of RCC across localised, locally-advanced, and metastatic disease.
EAU 2025 Guidelines: Non-muscle-invasive Bladder Cancer
Diagnosis, risk stratification, treatment, and surveillance of non-muscle-invasive bladder cancer (TaT1 and CIS) urothelial carcinoma.
EAU 2025 Guidelines: Muscle-invasive and Metastatic Bladder Cancer
Diagnosis, staging, and treatment of muscle-invasive (cT2–T4) and metastatic urothelial bladder cancer, covering neoadjuvant chemotherapy, radical cystectomy, bladder-sparing trimodality therapy, and systemic treatment of metastatic disease.
EAU 2025 Guidelines: Upper Urinary Tract Urothelial Carcinoma
Diagnosis, risk stratification, kidney-sparing and radical surgical management, peri-operative systemic therapy, and follow-up of urothelial carcinoma of the renal pelvis and ureter.
EAU 2025 Guidelines: Prostate Cancer
Multi-society recommendations for screening, diagnosis, staging, treatment, and follow-up of prostate cancer — from early detection through localised, biochemically recurrent, hormone-sensitive metastatic, and castration-resistant disease.
EAU 2025 Guidelines: Testicular Cancer
Diagnosis, staging, and management of germ cell tumours (seminoma and non-seminoma) across all clinical stages, with risk-adapted treatment driven by IGCCCG prognostic groups and fertility preservation.
EAU 2025 Guidelines: Primary Urethral Carcinoma
Diagnosis, staging, and stage- and sex-specific management of primary urethral carcinoma, a rare (<1% of GU malignancies) cancer covering urothelial, squamous and adenocarcinoma histologies.
EAU 2025 Guidelines: Penile Cancer
EAU-ASCO joint recommendations on pathology, diagnosis, staging, and multidisciplinary management of penile squamous cell carcinoma, including organ-sparing surgery, sentinel node biopsy, and multimodal therapy.
EAU 2025 Guidelines: Urolithiasis
Full-spectrum management of urinary stone disease — diagnostic imaging, metabolic evaluation, acute renal colic, interventional treatment (SWL, URS, PCNL), special populations, and recurrence prevention.
EAU 2025 Guidelines: Urethral Strictures
Diagnosis and management of urethral strictures in male, female, and transgender patients, covering endoluminal treatment (DVIU, dilatation), urethroplasty, posterior urethral injury, and follow-up.
EAU 2025 Guidelines: Urological Infections
Diagnosis, treatment, and prevention of bacterial UTIs across the spectrum — cystitis, pyelonephritis, urosepsis, catheter-associated UTI, prostatitis, epididymitis, Fournier's gangrene, GU TB, and peri-procedural prophylaxis.
EAU 2025 Guidelines: Urological Trauma
Evaluation and management of injuries to the kidney, ureter, bladder, urethra, and external genitalia — blunt, penetrating, and iatrogenic — with haemodynamic stability as the primary management criterion.
EAU 2025 Guidelines: Non-Neurogenic Male LUTS
Assessment, conservative management, drug therapy (alpha-blockers, 5-ARIs, antimuscarinics, beta-3 agonists, PDE5-i), and the full range of surgical options for benign prostatic obstruction stratified by prostate volume.
EAU 2025 Guidelines: Non-neurogenic Female LUTS
Assessment and management of LUTS in women — stress, urge, and mixed incontinence, overactive bladder, female BOO, nocturia, prolapse-associated LUTS, urinary fistulae, and urethral diverticula.
EAU 2025 Guidelines: Chronic Pelvic Pain
Diagnosis and bio-psychosocial management of Chronic Primary Pelvic Pain Syndromes — primary prostate, bladder, scrotal, urethral, and anorectal pain syndromes, plus pudendal neuralgia and pelvic floor dysfunction.
EAU 2025 Guidelines: Neuro-Urology
Management of neurogenic lower urinary tract dysfunction (NLUTD) in adults with SCI, MS, Parkinson's, stroke, and spina bifida — prioritising upper tract protection, continence, and quality of life.
EAU 2025 Guidelines: Sexual and Reproductive Health
Diagnosis and management of male sexual dysfunction (ED, ejaculatory disorders, low desire), penile conditions (Peyronie's, curvature, priapism), male hypogonadism, and male infertility.
EAU 2025 Guidelines: Paediatric Urology
Full breadth of paediatric urological conditions — phimosis, undescended testes, hypospadias, varicocele, VUR, hydronephrosis, stones, posterior urethral valves, DSD, paediatric tumours, and emergencies.
EAU 2025 Guidelines: Renal Transplantation
Full kidney transplantation pathway — donor selection (living and deceased), retrieval and preservation, recipient assessment, surgery, immunosuppression, and management of surgical and immunological complications.
Educational use only. These guidelines are reproduced for study purposes. Always refer to the official EAU website at eau.org for the latest clinical recommendations.